Los mejores podcasts de Mafld (2024)

1
S5 - E25 - Reviewing Expert Recommendations on the Use of Resmetirom 42:02

3M ago42:02

42:02

Por HEP Dynamics LLC

1
S4 - E24.5 - SurfingMASH Question of The Week: Keys to Improving Provider-Patient Communication 20:14

3M ago20:14

20:14

Two weeks ago, the SurfingMASH Question of the Week asked, "What structural or educational changes do you anticipate will significantly improve Provider-Patient communication? Will these changes require more from the provider and more from the patient?" Today, S5 E23 panelists Mike Betel and José Willemse join Roger Green to review the three answer…

1
S5 - E24.4 - EASL Congress Six Weeks Later: Jeff McIntyre's Key Implications for GLI 18:28

3M ago18:28

18:28

In the second half of Roger Green's interview with Global Liver Institute Vice President, Liver Programs Jeff McIntyre, Jeff discusses the implications of his key EASL Congress takeaways for GLI and other patient advocacy groups. To Jeff, this trend makes patient advocates a more valuable player in the clinical trial design process, particularly wh…

1
S5 - E24.3 - EASL Congress Six Weeks Later: Jeff McIntyre's Key Takeaways 12:46

3M ago12:46

12:46

This conversation contains the first half of Roger Green's interview with Global Liver Institute Vice President, Liver Programs Jeff McIntyre, during which the two discuss what Jeff considered the key strategic takeaways for GLI from the various EASL Congress presentations, abstracts and discussions. Jeff focuses on the "overriding sense of optimis…

1
S5 - E24.2 - EASL Congress Six Weeks Later: Mathieu Petitjean's Key Implications 10:58

3M ago10:58

10:58

In the second half of Roger Green's interview with PharmaNest Founder and CEO Mathieu Petitjean, Matt discusses the implications of his key EASL Congress takeaways for PharmaNest. Matt starts this discussion with a simple question: Will biopsy-based analyses become part of a surrogate endpoint? As he points out, they are not today, and creating the…

1
S5 - E24.1 - EASL Congress Six Weeks Later: Mathieu Petitjean's Key Takeaways 17:10

3M ago17:10

17:10

This conversation contains the first half of Roger Green's interview with PharmaNest Founder and CEO Mathieu Petitjean. After Matt tells the audience a little about his background and PhramaNest, the two discuss what Matt considered the key strategic takeaways for PharmaNest from the various EASL Congress presentations, abstracts and discussions. B…

1
S5 - E24 - A view of MASLD: Looking back at EASL Congress from six weeks later 1:16:26

4M ago1:16:26

1:16:26

00:00:00 - Surf's Up: Season 5 Episode 24 This week's episode on MASLD lessons from the EASL Congress 2024 includes three separate elements: individual interviews with PharmaNext Founder and CEO Mathieu Petitjean and Global Liver Institute Vice President of Liver Programs Jeff McIntyre, followed by a discussion with patient advocates Mike Betel of …

1
S5 SPECIAL 5 - Reviewing EASL Congress: Louise Campbell 3 (first-time material) 9:48

4M ago9:48

9:48

This week, Surfing the MASH Tsunami looks back on interviews Roger Green conducted during the EASL Congress itself. This conversation with SurfingMASH co-host and Tawazun Health Founder and Clinical Director Louise Campbell took place on the last day of the Congress This portion of the conversation was not included in the original S5 E19 but instea…

1
S5 SPECIAL 4 - Reviewing EASL Congress: Sven Francque 17:12

4M ago17:12

17:12

This week, Surfing the MASH Tsunami looks back on interviews Roger Green conducted during the EASL Congress itself. This conversation with Hepatology Key Opinion Leader and EASL Educational Councillor Sven Francque took place 90 minutes after the EASL Congress closed. The discussion focuses on plans and hopes for the future, both the future of MASL…

1
S5 SPECIAL 3 - Reviewing EASL Congress: Louise Campbell 2 20:47

4M ago20:47

20:47

This week, Surfing the MASH Tsunami looks back on interviews Roger Green conducted during the EASL Congress itself. This conversation with SurfingMASH co-host and Tawazun Health Founder and Clinical Director Louise Campbell took place on the last day of the Congress. This conversation centered on three major topics addressed at the EASL Congress, e…

1
S5 SPECIAL 2 - Reviewing EASL Congress: Louise Campbell I 20:13

4M ago20:13

20:13

This week, Surfing the MASH Tsunami looks back on interviews Roger Green conducted during the EASL Congress itself. This conversation with SurfingMASH co-host and Tawazun Health Founder and Clinical Director Louise Campbell took place on the first day of the Congress. Roger's first interview with Louise took place at the end of Thursday, the openin…

1
S5 SPECIAL 1 - Reviewing EASL Congress: Mike Betel 13:04

4M ago13:04

13:04

This week, Surfing the MASH Tsunami looks back on interviews Roger Green conducted during the EASL Congress itself. This conversation with Fatty Liver Alliance Founder and CEO Mike Betel took place Wednesday of Congress week, a day for special sections and industry presentations, but one day before the General Session opened. The first part of the …

1
S5 - E23.6 - From The Vault: Improving Patient Self-Management And Key Takeaways On Nutrition For MASH Resolution 29:50

4M ago29:50

29:50

This week’s vault comes from our first episode with Shira Zelber-Sagi. She and Ken Cusi joined us during US Thanksgiving Week 2022 to discuss nutrition and behavioral issues related to MASLD. The episode’s original writeup explains: Surfing the MASH Tsunami hosts its first episode dedicated to nutrition and NASH with distinguished guest, Prof. Shir…

1
S5 - E23.5 - From the EASL Congress: The Need for Shared Experience MASLD Support Groups and Programs 11:45

4M ago11:45

11:45

Co-chairs Shira Zelber-Sagi and Mike Betel and panelists Tom Marjot and José Willemse, all from the EASL Congress session "Patient Experiences in Clinical Settings," join Louise Campbell to the need for resources that allow MASLD patients to access shared experience programs and holistic MASLD support programs. This final conversation focuses on sh…

1
S5 - E23.4 - From the EASL Congress: Socioeconomic And Psychological Issues In The Physician-Patient Dialogue 12:20

4M ago12:20

12:20

Co-chairs Shira Zelber-Sagi and Mike Betel and panelists Tom Marjot and José Willemse, all from the EASL Congress session "Patient Experiences in Clinical Settings," join Louise Campbell to discuss ways that socioeconomic and psychological issues impact the dynamic of the physician-patient consult, and, as a result, often patient adherence to thera…

1
S5 - E23.3 - From The EASL Congress: Improving The Physician-Patient Dialogue 12:25

4M ago12:25

12:25

Co-chairs Shira Zelber-Sagi and Mike Betel and panelists Tom Marjot and José Willemse, all from the EASL Congress session "Patient Experiences in Clinical Settings," join Louise Campbell to discuss strategies and questioning styles that can improve the dynamic of the physician-patient consult. This conversation starts with Tom stating that having m…

1
S5 - E23.2 - From The EASL Congress: Dynamics Of The Physician-Patient Dialogue 11:29

4M ago11:29

11:29

Co-chairs Shira Zelber-Sagi and Mike Betel and panelists Tom Marjot and José Willemse, all from the EASL Congress session "Patient Experiences in Clinical Settings," join Louise Campbell to discuss some of the key dynamics shaping the physician-patient consult. This conversation starts with Mike asking Tom whether he reviews the patient's history b…

1
S5 - E23.1 - From The EASL Congress: Overview Of Challenges In Physician-Patient Communication 14:38

4M ago14:38

14:38

Co-chairs Shira Zelber-Sagi and Mike Betel and panelists Tom Marjot and José Willemse, all from the EASL Congress session "Patient Experiences in Clinical Settings," join Louise Campbell to provide an overview of issues in physician-patient communication. The conversation itself has two elements. It starts with first-time surfers Tom Marjot and Jos…

1
S5 - E23 - Lessons from EASL Congress: Challenges in Provider-Patient Communication 58:52

4M ago58:52

58:52

00:00:00 - Surf's Up: Season 5 Episode 23 During SurfingMASH's wrap-up interviews from the EASL Congress (S5 E19), Louise Campbell and Mike Betel mentioned a session Mike co-chaired on challenges in provider-patient communications. Today, the other co-chair, Shira Zelber-Sagi and panelists Tom Marjot and Jose Willemse join Louise and Mike to return…

1
S5 - E22.6 - FROM THE VAULT: Patient Advocates Reflect On How The "System" Views MASH 12:29

4M ago12:29

12:29

In this week's episode, Jeff Lazarus discusses the idea that the MASH community, including patient advocates, live in a "bit of a bubble," where the clinicians with whom they interact are part of the MASH community. Last year's ICER Public Comments session exposed them to an FDA Advisory Board of hepatologists...and it was a very different experien…

1
S5 - E22.5 - Healthy Livers, Healthy Lives: Watershed Moments To Come In MASLD Publlc Policy 10:49

4M ago10:49

10:49

In this closing conversation, Healthy Livers, Healthy Lives Chair Jeff Lazarus and Surfers Jörn Schattenberg, Louise Campbell and Roger Green discuss the upcoming United Nations General Assembly side event and consider ways listeners can support the "Healthy LIvers, Healthy Lives" coalition. Jeff discussed this impact on global care when the World …

1
S5 - E22.4 - Healthy Livers, Healthy Lives: The Role Of The Updated EASL MASLD Guidelines And Big Data 10:44

5M ago10:44

10:44

Healthy Livers, Healthy Lives Chair Jeff Lazarus joins Jörn Schattenberg, Louise Campbell and Roger Green to discuss the value of the updated EASL/EASD/EASO MASLD clinical practice guidelines and consider the role of Big Data in early MASLD screening. Roger asks Jeff whether he considers the updated MASLD CPG a step forward. Jeff praises the guidel…

1
S5 - E22.3 - Healthy Livers, Healthy Lives: Challenges and Promise in Building a Global MASLD Health Policy 10:54

5M ago10:54

10:54

Healthy Livers, Healthy Lives Chair Jeff Lazarus joins Jörn Schattenberg, Louise Campbell and Roger Green to discuss some of the specific structural challenges that confront global MASLD public policy, along with some promising local activities. Louise observes that, in her experience, primary care practitioners appreciate the support that speciali…

1
S5 - E22.2 - Healthy Livers, Healthy Lives: "Political Will" In MASLD Public Policy 12:14

5M ago12:14

12:14

Healthy Livers, Healthy Lives Chair Jeff Lazarus joins Jörn Schattenberg, Louise Campbell and Roger Green to discuss why political will is so important in overcoming inertia and obstruction in global MASLD public health policy. Louise notes that she left NHS because of obstruction against earlier stage efforts to promote liver health and asks how t…

1
S5 - E22.1 - Healthy Livers, Healthy Lives: Why MASHville Needs This Coalition 13:29

5M ago13:29

13:29

Healthy Livers, Healthy Lives Chair Jeff Lazarus joins Jörn Schattenberg, Louise Campbell and Roger Green to discuss how the coalition came into existence and to describe two initiatves aimed at increasing early screening. Jeff starts the conversation by describing the "bit of a bubble" in which the MASLD community lives: great news and lots of exc…

1
S5 - E22 - Healthy Livers, Healthy Lives: A Global SLD Public Health Coalition 45:08

5M ago45:08

45:08

00:00:00 - Surf's Up: Season 5 Episode 22 Jeff Lazarus joins Jörn Schattenberg, Louise Campbell and Roger Green to discuss Healthy Livers, Healthy Lives, a coalition of four major professional organizations (AASLD, ALEH, APASL and EASL) and other partners. This coalition works with other specialties to create global public health awareness and driv…

1
S5 - E21.6 - From The Vault: Comments On The 2023 AASLD Revised Practice Guidance 11:05

5M ago11:05

11:05

This week's vault conversation looks back 17 months when Ken Cusi joined co-hosts Louise Campbell, Jörn Schatenberg and Roger Green to discuss the revised AASLD Practice Guidance that had been issued the previous week. At the time, here was SurfingMASH's summary of the conversation: Late last week, AASLD published new practice guidance on the clini…

1
S5 - E21.5 - The Updated MASLD CPG: Implications For Healthcare Systems 12:08

5M ago12:08

12:08

In this closing conversation, updated MASLD CPG co-authors Frank Tacke and Elisabetta Bugianesi and podcast co-hosts Louise Campbell and Roger Green consider what the guidelines might foretell in changes in provider education, structure of patient visits and treatment in less affluent or medically advanced countries. The last set of questions begin…

1
S5 - E21.4 - The Updated MASLD CPG: Pharmacology And New Educational Needs 11:04

5M ago11:04

11:04

For most of this conversation, updated MASLD CPG co-authors Frank Tacke and Elisabetta Bugianesi discuss key issues related to pharmacology and prescribing choices. At the end, the focus shifts to the guidelines' overall benefits and some new kinds of education they call for. The conversation starts with co-host Roger Green asking about key issues …

1
S5 - E21.3 - The Updated MASLD CPG: Screening, Diagnosing And Managing Patients 13:20

5M ago13:20

13:20

In this conversation, updated MASLD CPG co-authors Frank Tacke and Elisabetta Bugianesi discuss some of the guidelines' key goals and issues surrounding the screening, diagnosis and management of MASLD patients. As the conversation starts, co-host Roger Green says that he, too, was impressed that all these adjustments were made within a month at th…

1
S5 - E21.2 - The Updated MASLD CPG: Benefits Of The Collaboration 11:00

5M ago11:00

11:00

In this conversation, updated MASLD CPG co-authors Frank Tacke and Elisabetta Bugianesi explain how the guidelines process benefitted from the close collaboration between EASL, EASD, and EASO. The conversation starts with Elisabetta conveying the "big advantage" that came from this collaboration. The presence of the three organizations conveyed the…

1
S5 - E21.1 - The Updated MASLD CPG: Introductions 9:21

5M ago9:21

9:21

Two of the co-authors of the upgraded MASLD Clinical Practice Guidelines, Elisabetta Bugianesi and Frank Tacke join Louise Campbell and Roger Green to discuss the guidelines. The theme for the conversation is "introductions". First, the audience is introduced to co-authors Elisabetta Bugianesi and Frank Tacke, neither of whom has Surfed the Tsunami…

1
S5 - E21 - Reviewing The Updated ESL-EASD-EASO MASLD Clinical Practice Guidelines 52:15

5M ago52:15

52:15

00:00:00 - Surf's Up: Season 5 Episode 21 One important session at the EASL Congress 2024 involved the presentation of the new MASLD Clinical Practice Guidelines. CPG co-authors Elisabetta Bugianesi and Frank Tacke join Louise Campbell and Roger Green to share their perspectives on the guidelines' development some key recommendations. 00:09:36 - Re…

1
S5 - E20.6 - From the Vault: FGF-21s and "Twin-cretins" At EASL Congress 2023 14:25

5M ago14:25

14:25

In this conversation from July 2023, Stephen Harrison, Jörn Schattenberg and Roger Green discuss the implications of presentations on the FGF-21 agent efruxifermin and the dual GLP/glucagon agonists pemvidutide and efinopegdutide. Here is the description Roger wrote for the original conversation: In this session, conversation shifts from resmetirom…

1
S5 - E20.5 - Drug Development Highlights From EASL Congress 2024: Denifenstat, SPECIAL and Other Stories 13:28

5M ago13:28

13:28

Mazen Noureddin and Naim Alkhouri join Jörn Schattenberg and Roger Green to discuss some of the other major drug development stories from the EASL Congress 2024, with special focus on denifenstat, ION-224 and TAK-227, and to review the SPECIAL study on bariatric surgery and cirrhosis. The panelists concur that all three of these agents have potenti…

1
S5 - E20.4 - Drug Development Highlights From EASL Congress 2024: Are FGF-21s Induction Therapy or a "MASH Cure"? 10:05

5M ago10:05

10:05

Mazen Noureddin and Naim Alkhouri join Jörn Schattenberg and Roger Green to focus on the role FGF-21s will play in long-term advanced fibrosis treatment: induction or long-term therapy...or might we even think of the class as being able to produce a "MASH cure?" Responding to Naim's comment closing the previous discussion, Mazen questions why we re…

1
S5 - E20.3 - Drug Development Highlights From EASL Congress 2024: "Twin-cretins" and efruxifermin 14:35

5M ago14:35

14:35

Naim Alkhouri and Mazen Noureddin join Jörn Schattenberg and Roger Green to discuss issues regarding incretin agonists and results from the efruxiermin late-breaker at the EASL Congress 2024. Naim shares his general excitement about glucagon agents in general. He mentions that the efinopegdutide study included a semaglutide cell, which showed furth…

1
S5 - E20.2 - Drug Development Highlights From EASL Congress 2024: Tirzepatidate and other "Twin-cretins" 11:46

5M ago11:46

11:46

Mazen Noureddin and Naim Alkhouri join Jörn Schattenberg and Roger Green to discuss the tirzepatide late-breaker at the EASL Congress 2024 and other "Twin-cretins," all of which are GLP-glucagon combinations. "Twin-cretins" is the name Jörn has coined for agents with a GLP-1 agonist plus another incretin effect. Tirzepatide is a GLP/GIP agent, whil…

1
S5 - E20.1 - Drug Development Highlights From EASL Congress 2024: Resmetirom 10:51

5M ago10:51

10:51

Naim Alkhouri and Mazen Noureddin join Jörn Schattenberg and Roger Green to discuss some of the new research on resmetirom at the EASL Congress 2024. Mazen begins this discussion by covering a paper he presented on Stephen's behalf, looking at dose-response with resmetirom. The analysis indicated that PDFF and histology improvements at the 100mg do…

1
S5 - E20 - Lessons From EASL Congress 2024: Exciting Advances in Drug Development 57:35

5M ago57:35

57:35

00:00:00 Surf's Up, Season 5 Episode 20 Naim Alkhouri and Mazen Noureddin join co-hosts Jörn Schattenberg and Roger Green to discuss major drug development stories from the EASL Congress 2024. They pay tribute to Stephen Harrison and proceed to groundbreakers. 00:08:16 - Presentations on Resmetirom Mazen shares a paper he presented looking at resme…

1
EASL Congress 2024: Interviews From A Seminal Meeting For MASLD & MASH 1:10:16

5M ago1:10:16

1:10:16

00:00:00 - Surf's Up: Season 5 Episode 19 During EASL Congress 2024, US-based Roger Green, conducted interviews with Mike Betel, Louise Campbell (twice) and Sven Francque from Milano. These interviews focused on the major MASLD themes and presentations at the event. 00:04:14 - Conversation with Mike Betel begins On Wednesday, the first afternoon of…

1
S5 - E18.5 - How Listeners Can Support HOPE, A Unique Support Community For People Who Have Harmed Their Bodies Through Alcohol Use Disorder 9:33

5M ago9:33

9:33

In this final conversation, Sober Livers leaders Jenn Jones and Beth Lehman share what they hope listeners will take from this discussion of HOPE (Healing Others with Peers and Education) and how they can help this unique support program grow. The conversation starts with Roger asking what Sober Livers and/or transplant centers can do to help patie…

1
S5 - E18.4 - The Future Of HOPE: Expanding the Support Community for Patients Who Have Harmed Their Bodies Through Alcohol Use Disorder 10:25

5M ago10:25

10:25

Sober Livers leaders Jenn Jones and Beth Lehman join Roger Green to discuss HOPE, their new support community for people who have harmed themselves through AUD (Alcohol Use Disorder). This conversation focuses on plans and hopes for the future. Roger starts this conversation by sharing a story from his own experience about the pressure caregivers s…

1
S5 - E18.3 - Specific Support Elements HOPE Provides For People Who Have Harmed Themselves Due To Alcohol Use Disorder 11:01

5M ago11:01

11:01

In this conversation, Society of Sober LIvers leaders Jenn Jones and Beth Lehman describe the HOPE (Healing Others with Peers and Education) program. They go on to discuss why version 1.0 does not include specific support for caregivers. Jenn describes the program's core elements, starting with a monthly video call that is a support meeting one mon…

1
S5 - E18.2 - Why People Who Have Harmed Themselves Through Alcohol Use Disorder Need HOPE 9:17

5M ago9:17

9:17

This conversation focuses on the target population of patients with AUD (Alcohol Use Disorder) with decompensated cirrhosis and asks why this group needs a support community like HOPE (Healing Others with Peers and Education). Roger asks what makes people who have harmed their bodies through AUD a unique community as compared to other communities p…

1
S5 - E18.1 - Introducing HOPE, A Project For People Who Have Harmed Their Bodies Through Alcohol Use DIsorder 12:03

5M ago12:03

12:03

This conversation re-introduces us to Sober Livers Founder/Visionary Jenn Jones and introduces us to Beth Lehman, Principal Strategic Advisor to Sober Livers and HOPE, a multi-element patient support program for people who have harmed their livers though AUD (Alcohol Use Disorder). As this conversation starts, we meet Beth Lehman, Principal Strateg…

1
S5 - E18 - Introducing HOPE, a support program for patients living with the effects of ALD and cirrhosis 48:29

6M ago48:29

48:29

Roger Green is joined by Sober Livers Founder/Visionary Jenn Jones and Principal Strategic Advisor Beth Lehman to discuss HOPE, a support program launching June 11 for people who have harmed their bodies through ALD and its consequences. 00:00:00 - Surf's Up: Season 5 Episode 18 Standard lead-in, including quotes from panelists 00:02:07 - Introduct…

1
S5 - E17.6 - From The Vault: Looking Back At The EASL Congress 2023 Preview & Program Design 17:13

6M ago17:13

17:13

This week's Vault looks back to the EASL Congress 2023 and includes Aleksander Krag, Sven Francque and all three surfers: Jörn Schattenberg, Louise Campbell and Roger Green. The focus of this conversation revolves around program design. The original conversation came with a robust description: This conversation starts with Roger’s question to Sven …

1
S5 - E17.5 - Previewing EASL Congress 2024: Focusing On MASLD Drug Development 12:52

6M ago12:52

12:52

This final conversation from SurfingMASH's EASL Congress 2024 preview includes two final papers, one covering MASLD drug development, and a diverse set of answers to Roger Green's closing question. Jörn Schattenberg discusses a paper he will present on a completely new concept to treat MASLD, a Phase 2a trial of a transglutaminase inhibitor, a comp…

1
S5 - E17.4 - Previewing EASL Congress 2024: Is Big Data The Future Of MASLD? 12:19

6M ago12:19

12:19

This conversation revolves largely around two Big Data presentations Hannes Hagstrom's team is sharing at the EASL Congress. Every other panelist has at least one meaningful comment to make about the future of Big Data in MASLD. Hannes describes two big data studies of his own, "very much Big Data, but it's not omics." One examined 860,000 resident…

Podcasts que vale la pena escuchar

Podcasts de Mafld

Podcasts que vale la pena escuchar

Guia de referencia rapida